Metformin (Formin (500 mg)) is an oral antidiabetic agent, prescribed for type 2 diabetes. It helps control blood sugar levels. The information provided on this page is intended to serve as a ...

Parkinsons disease was the metformin 500 mg generic neurological disorder to be associated with deficiency of a specific neurotransmitter. In Parkinsons disease, there is a deficiency of dopamine in ...

Adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes who are not adequately controlled on metformin or sitagliptin alone or in patients already being treated with ...

When Is the Best Time to Take Metformin? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. We get it — no one enjoys ...

LAKELAND, Fla. Publix launched the first phase of its new diabetes management system, a multifaceted program designed to assist customers and associates living with diabetes. In its first phase, the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Patients with poorly controlled type 2 ...

The US Food and Drug Administration (FDA) has approved a fixed-dose combination product combining the sodium glucose cotransporter 2 (SGLT2) inhibitor canagliflozin with metformin hydrochloride for ...

The polycystic ovary syndrome (PCOS) is defined as the presence of both ovulatory dysfunction and hyperandrogenism. In women with PCOS, oligo- or anovulation manifests itself as irregular cycles with ...

For the second time in a week, a maker of Type 2 diabetes drug Metformin announced a recall because the drug might have too much NDMA, a substance that can cause cancer in certain amounts. The FDA ...

For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...

A new research paper was published in Oncotarget's Volume 14 on June 19, 2023, entitled, "Utilizing metformin to prevent metabolic syndrome due to androgen deprivation therapy (ADT): a randomized ...

ORLANDO, Fla.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results up to 76-weeks from a Phase 3 study of ONGLYZA ™ (saxagliptin) as initial ...